SCHEMBL24915862

SCHEMBL24915862

COc1cc(C(=O)N2CCCC2)c2nccc(C(C)C)c2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.46
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 2/20 0.46
HSD17B10 Q99714 1/20 0.46
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
RAB9A P51151 4/20 0.42
POLB P06746 2/20 0.42
CPS1 P31327 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPC1 O15118 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SYK P43405 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24915955 0.91 ALDH1A1 (0.44) HPGDALDH1A1KDM4EHSD17B10GAA
SCHEMBL24915956 0.90 HSP90AA1 (0.47) HPGDALDH1A1KDM4EHSD17B10GAA
SCHEMBL24915853 0.82 LMNA (0.50) HPGDALDH1A1KDM4EHSD17B10GAA
SCHEMBL24915856 0.81 JAK2 (0.42) HPGDALDH1A1KDM4EGLAGAA
SCHEMBL24915860 0.81 RPS6KB1 (0.52) KDM4E
SCHEMBL24915857 0.79 LMNA (0.39) KDM4ECYP1A2CYP2C19SYKNPSR1
SCHEMBL24915854 0.79 MTNR1A (0.43) HPGDALDH1A1KDM4EHSD17B10GLA
SCHEMBL24916220 0.78 DPP4 (0.45) HPGDALDH1A1KDM4EGLAGAA
SCHEMBL24915957 0.76 LRRK2 (0.45) HPGDALDH1A1KDM4EHSD17B10GAA
SCHEMBL24916219 0.72 PDE10A (0.41) HPGDALDH1A1KDM4EHSD17B10GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026466-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 HPGD 3370/4885ALDH1A1 3815/4885KDM4E 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.